NFATC1 and urinary bladder carcinoma: Using bladder cancer lines, we here demonstrated that they overexpressed NFATc1 and that silencing of NFATc1 resulted in significant decreases, similar to those by CsA or FK506 treatment, in cell viability and invasion.